Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his ...
Dr. Jonathan Daly, an internal medicine physician who worked for Hims for two years, told the Journal that he “felt like as a platform, it was more of the let’s go ahead and prescribe ...
Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...
This could impact Hims' ability to compound the medicine. While this presents a short-term challenge, the company’s diverse product categories and total addressable market remain strong.
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
The ability to collect more data on each subscriber is what will allow HIMS to offer even more personalized products and hence make traditional medicine as we know it even less valuable compared ...
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...
Janet Jackson’s infamous wardrobe malfunction may soon become the second most consequential Super Bowl off-field moment of the 21stcentury. A minute-long ad from telemedicine giant Hims/Hers has ...
He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor. Soon after taking the medicine, Millich said he felt strange symptoms.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results